Industry News

3 Sep

Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine

All vaccinated animals exposed to a lethal aerosol of ricin toxin survive Soligenix, Inc. (SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics,...

Read more

3 Sep

Anavex to Present at Rodman & Renshaw 16th Annual Global Investment Conference

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s disease, other diseases of the central nervous system (CNS) and various types of cancer, today announced that its President and Chief Executive Officer Christopher U. Missling, PhD, will be...

Read more

3 Sep

Actinium Files Orphan Drug Application for Use of Actimab-A in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients

Orphan Drug Designation Could Provide Faster Regulatory Review and Financial Incentives Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced it has filed an Application for Orphan Drug Designation with the U.S....

Read more

2 Sep

NXT-ID Patents Methods to Add Electronics to Make a Wallet Smart

 NXT-ID, Inc. (NXTD), a biometric authentication company focused on the growing mobile commerce market, announced today that it has submitted a patent application for methods to integrate intelligent systems into a wallet to form a smart wallet.  This patent primarily discusses mechanical methods and approaches to add electronics to...

Read more

29 Aug

Intellipharmaceutics Augments Its Rexista(TM) Oxycodone Development Program With Novel Overdose Deterrence Technology

Intellipharmaceutics International Inc. (IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced an enhancement of its Rexista(TM) abuse-deterrence technologies with a significant improvement designed to prevent overdose when more pills than prescribed are swallowed...

Read more

28 Aug

Stevia First Now Open for Business in a Really Big Way

For anyone new, thanks for visiting our blog, and for those of you who’ve been following along, then you are in for a surprise, as we have reached an all new milestone in the growth of our Company. Put simply, we’ve accelerated our commercialization plans, and today we’re selling...

Read more

Page 221 of 234« First...102030...219220221222223...230...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets


Follow this blog

Get every new post delivered right to your inbox.

Email address